Eton Pharmaceuticals Inc (ETON)

Eton Pharmaceuticals Inc (ETON) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.6B; returns 1 day -0.0%, 1 week -0.6%, 1 year +169.7%.

Eton Pharmaceuticals is a commercial-stage pharmaceutical company focused on developing and commercializing treatments for rare (orphan) diseases, primarily within the pediatric endocrinology and metabolic sectors. The business model utilizes a capital-efficient, asset-light strategy of acquiring or in-licensing late-stage, de-risked specialty drugs.

Groups ETON belongs to

• Pharmaceuticals
• Rare Diseases
• Commercial Stage
• Metabolic Disorders
• Endocrinology
• Healthcare
• Asset-Light Model

ETON financial model: income statement, cash flow and balance sheet